Evidence map›Paper›PMID 29051704›Full record

ArticlePalliative care2017

Palliation Versus Dialysis for End-Stage Renal Disease in the Oldest Old: What are the Considerations?

Lyle S Walton, Gregory D Shumer, Björg Thorsteinsdottir, Theodore Suh, Keith M Swetz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Palliative care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Frailty in CKD and Transplantation.Kidney international reports · 2021
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Lyle S WaltonDepartment of Medicine, University of Michigan, Ann Arbor, MI, USA.
Gregory D ShumerDepartment of Family Medicine, University of Michigan, Ann Arbor, MI, USA.
Björg ThorsteinsdottirDepartment of Medicine, Mayo Clinic, Rochester, MN, USA.
Theodore SuhDepartment of Medicine, University of Michigan, Ann Arbor, MI, USA.
Keith M SwetzDepartment of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.
University of Michigan–Ann Arbor · USBirmingham VA Medical Center · USMayo Clinic in Arizona · US

Funding

Evidence Based Encounter Decision Aid for Elderly Patients to Promote Shared Decision Making on Treatment Choice in End Stage Renal DiseaseK23AG051679 · NIA · MAYO CLINIC ROCHESTER · PI THORSTEINSDOTTIR, BJOERG · 2016 to 2020
$908k
NIA NIH HHS K23 AG051679
6 · The paper itself

Abstract

As the US population continues to age, new cases of end-stage renal disease (ESRD) in individuals, aged 85 years or older (the oldest old), are increasing. Many patients who begin hemodialysis despite questionable benefit may struggle with high symptom burden and rapid functional decline. This article reviews the history regarding the funding and development of the Medicare ESRD program, reviews current approaches to the oldest old with ESRD, and considers strategies to improve the management approach of this vulnerable population.

Indexed as

End-stage renal diseasehemodialysisMedicarepalliative carerenal replacement therapy

Identifiers

PMID29051704
PMCPMC5638155
OpenAlexW2761780692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.